COLUMBUS CIRCLE INVESTORS - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 135 filers reported holding TG THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.

Quarter-by-quarter ownership
COLUMBUS CIRCLE INVESTORS ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q4 2018$679,000
-49.8%
165,510
-31.4%
0.02%
-29.6%
Q3 2018$1,352,000
-86.2%
241,401
-67.7%
0.03%
-86.7%
Q2 2018$9,827,000
-9.1%
747,285
-1.8%
0.20%
-7.3%
Q1 2018$10,807,000
+141.8%
761,030
+39.6%
0.22%
+157.6%
Q4 2017$4,469,000
-75.4%
545,054
-64.4%
0.08%
-72.5%
Q3 2017$18,165,000
+29.4%
1,532,911
+9.8%
0.31%
+33.2%
Q2 2017$14,034,000
+19.9%
1,396,396
+39.0%
0.23%
+40.6%
Q1 2017$11,702,000
+224.0%
1,004,421
+29.3%
0.16%
+251.1%
Q4 2016$3,612,000
-26.6%
776,699
+22.2%
0.05%
-11.3%
Q3 2016$4,918,000
+40.5%
635,360
+10.0%
0.05%
+51.4%
Q2 2016$3,501,000
-32.9%
577,769
-5.7%
0.04%
-25.5%
Q1 2016$5,220,000
-38.0%
612,714
-13.1%
0.05%
-29.9%
Q4 2015$8,415,000
+26.3%
705,389
+6.7%
0.07%
+21.8%
Q3 2015$6,665,000
-13.6%
661,199
+42.1%
0.06%0.0%
Q2 2015$7,717,000
+8.1%
465,180
+0.8%
0.06%
+12.2%
Q1 2015$7,142,000
+96.3%
461,399
+100.8%
0.05%
+88.5%
Q4 2014$3,639,000
-25.5%
229,731
-49.8%
0.03%
-25.7%
Q3 2014$4,884,000
+27.2%
457,712
+11.9%
0.04%
+34.6%
Q2 2014$3,840,000
+123.3%
408,962
+64.1%
0.03%
+136.4%
Q1 2014$1,720,000
+172.6%
249,245
+53.9%
0.01%
+175.0%
Q4 2013$631,000161,9190.00%
Other shareholders
TG THERAPEUTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
RA Capital Management 6,880,323$38,633,0002.30%
Eversept Partners, LP 773,501$4,343,2081.35%
Opaleye Management Inc. 612,500$3,439,0001.24%
BRIDGER MANAGEMENT, LLC 2,334,196$13,107,0001.08%
Sofinnova Investments, Inc. 1,733,628$9,734,0000.88%
PURA VIDA INVESTMENTS, LLC 354,719$1,992,0000.34%
683 Capital Management, LLC 400,000$2,246,0000.25%
NEXPOINT ASSET MANAGEMENT, L.P. 649,460$3,646,0000.23%
Artal Group S.A. 900,000$5,054,0000.20%
Frontier Wealth Management LLC 226,750$1,273,0000.19%
View complete list of TG THERAPEUTICS INC shareholders